PCM
NGM

Prelude Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Prelude Capital Management’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,416
Closed -$27K – 1326
2023
Q2 		$27K Buy
+10,416
New +$27K ﹤0.01% 885
2019
Q4 		– Sell
-20,435
Closed -$283K – 1851
2019
Q3 		$283K Buy
+20,435
New +$283K 0.01% 385